Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.
2.

Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death.

Schmidt J, Barthel K, Zschüntzsch J, Muth IE, Swindle EJ, Hombach A, Sehmisch S, Wrede A, Lühder F, Gold R, Dalakas MC.

Brain. 2012 Apr;135(Pt 4):1102-14. doi: 10.1093/brain/aws046.

PMID:
22436237
3.

Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.

Kierdaszuk B, Berdynski M, Palczewski P, Golebiowski M, Zekanowski C, Kaminska AM.

Folia Neuropathol. 2015;53(4):355-66.

4.

Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis.

Vattemi G, Nogalska A, King Engel W, D'Agostino C, Checler F, Askanas V.

Acta Neuropathol. 2009 May;117(5):569-74. doi: 10.1007/s00401-009-0511-6.

PMID:
19280202
5.
6.

Inclusion body myositis: new insights into pathogenesis.

Garlepp MJ, Mastaglia FL.

Curr Opin Rheumatol. 2008 Nov;20(6):662-8. doi: 10.1097/BOR.0b013e328313644c. Review.

PMID:
18946325
7.

Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins.

Page LJ, Suk JY, Bazhenova L, Fleming SM, Wood M, Jiang Y, Guo LT, Mizisin AP, Kisilevsky R, Shelton GD, Balch WE, Kelly JW.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11125-30. doi: 10.1073/pnas.0811753106.

8.

Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse.

Luo YB, Johnsen RD, Griffiths L, Needham M, Fabian VA, Fletcher S, Wilton SD, Mastaglia FL.

Int J Exp Pathol. 2013 Dec;94(6):418-25. doi: 10.1111/iep.12048.

9.

Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.

Mirabella M, Alvarez RB, Engel WK, Weisgraber KH, Askanas V.

Ann Neurol. 1996 Dec;40(6):864-72.

PMID:
9007091
14.

Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.

Fukuchi K, Pham D, Hart M, Li L, Lindsey JR.

Am J Pathol. 1998 Dec;153(6):1687-93.

15.

Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers.

Fratta P, Engel WK, Van Leeuwen FW, Hol EM, Vattemi G, Askanas V.

Neurology. 2004 Sep 28;63(6):1114-7.

PMID:
15452314
16.

An ER-directed gelsolin nanobody targets the first step in amyloid formation in a gelsolin amyloidosis mouse model.

Van Overbeke W, Wongsantichon J, Everaert I, Verhelle A, Zwaenepoel O, Loonchanta A, Burtnick LD, De Ganck A, Hochepied T, Haigh J, Cuvelier C, Derave W, Robinson RC, Gettemans J.

Hum Mol Genet. 2015 May 1;24(9):2492-507. doi: 10.1093/hmg/ddv010.

17.

Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers.

Nogalska A, D'Agostino C, Terracciano C, Engel WK, Askanas V.

Am J Pathol. 2010 Sep;177(3):1377-87. doi: 10.2353/ajpath.2010.100050.

18.
19.
20.

Transthyretin Val122Ile, accumulated Abeta, and inclusion-body myositis aspects in cultured muscle.

Askanas V, Engel WK, McFerrin J, Vattemi G.

Neurology. 2003 Jul 22;61(2):257-60.

PMID:
12874414
Items per page

Supplemental Content

Support Center